Neovascular Age-related Macular Degeneration

• CLINICAL_TRIALS trial_result · 2011-05-12
  Clinical Trial Update: Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) [Phase 1]

  Phase 1 study update for AdGVPEDF.11D in neovascular age-related macular degeneration; the GenVec-sponsored trial has completed.

• CLINICAL_TRIALS trial_result · 2011-05-02
  Clinical Trial Update: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Phase 3]

  A Phase 3 trial comparing verteporfin PDT plus intravitreal triamcinolone versus verteporfin PDT plus intravitreal pegaptanib for age-relate…

• CLINICAL_TRIALS trial_result · 2011-04-21
  Clinical Trial Update: Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD [Phase 1]

  A Phase 1 study evaluating the safety and tolerability of intravitreal VEGF trap formulations in patients with neovascular age-related macul…

• CLINICAL_TRIALS trial_result · 2010-10-27
  Clinical Trial Update: A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

  A completed real-life study assessing the efficacy of Macugen injections in neovascular age-related macular degeneration (AMD).

• CLINICAL_TRIALS trial_result · 2010-03-18
  Clinical Trial Update: Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) [Phase 1]

  A Phase 1 safety study of intravitreal POT-4 therapy for neovascular age-related macular degeneration has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2009-10-30
  Clinical Trial Update: Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD [Phase 2]

  Phase 2 trial evaluating the efficacy and safety of combining ranibizumab (Lucentis) with verteporfin (Visudyne) for neovascular age-related…

• CLINICAL_TRIALS trial_result · 2009-06-09
  Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1, Phase 2]

  A pilot Phase 1/Phase 2 trial evaluating the safety and efficacy of ORA102 in combination with Avastin versus Avastin alone for neovascular …

• CLINICAL_TRIALS trial_result · 2008-03-21
  Clinical Trial Update: The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD) [NA]

  Clinical trial update examining the effects of bevacizumab and ranibizumab on ocular pulse amplitude in neovascular age-related macular dege…

• CLINICAL_TRIALS trial_result · 2007-09-21
  Clinical Trial Update: Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD [Phase 3]

  This clinical trial update covers a Phase 3 study examining the long-term effects of frequent anti-VEGF dosing on retinal function in patien…

• CLINICAL_TRIALS trial_result · 2006-06-26
  Clinical Trial Update: Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study) [Phase 2]

  A completed Phase 2 prospective study (PrONTO) evaluating OCT-guided ranibizumab (Lucentis) treatment for neovascular age-related macular de…